Videx Ec
developed to target viral replication to support immune function.
Strengths: 400mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Nucleoside Reverse Transcriptase Inhibitor (NRTI)
- Pharmacological class
Nucleoside analogue
- Contraindications
hypersensitivity to didanosine
- Minor side effects
diarrhoea; nausea; vomiting; headache
- Moderate side effects
abdominal pain; peripheral neuropathy; elevated liver enzymes
- Dosage forms
Gastro-resistant capsule, hard
- Administration route
Oral use
- Patient summary
developed to target viral replication to support immune function.
- Prescription status
POM
- Manufacturer
Bristol-Myers Squibb
- Onset Time
1–2 hours
- Duration
12–24 hours
- Storage instructions
Store in original container in a cool, dry place.
- Drug interactions
alcohol; tenofovir; allopurinol
- Age restrictions
Consult physician for paediatric use.
Precautions and warnings
risk of life-threatening pancreatitis; monitor for peripheral neuropathy; monitor for lactic acidosis
Serious side effects
pancreatitis — requires immediate medical attention; lactic acidosis — requires immediate medical attention; hepatic steatosis — requires immediate medical attention
Mechanism of action
Didanosine is a nucleoside analogue that inhibits the HIV-1 reverse transcriptase enzyme. It integrates into viral DNA and terminates chain elongation, preventing further viral multiplication and helping manage infection progression.
Pregnancy and breastfeeding
Pregnancy: Use only if potential benefit outweighs risk. Breastfeeding: Not recommended for HIV-positive mothers.
Videx Ec
developed to target viral replication to support immune function.
Editorial Notes
- Active ingredient(s): Didanosine
- Listed indication(s): HIV Infection
Available option
- 30 tablets - 400 mg1503-400-mg-17997